Literature DB >> 19892968

Medicine. A comeback for gene therapy.

Luigi Naldini1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19892968     DOI： 10.1126/science.1181937

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

1.  DARPins: an efficient targeting domain for lentiviral vectors.

Authors:  Robert C Münch; Michael D Mühlebach; Thomas Schaser; Sabrina Kneissl; Christian Jost; Andreas Plückthun; Klaus Cichutek; Christian J Buchholz
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

Review 2.  Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.

Authors:  R Kohan; I A Cismondi; A M Oller-Ramirez; N Guelbert; Tapia V Anzolini; G Alonso; S E Mole; Dodelson R de Kremer; Noher I de Halac
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

3.  Combining stem cells and genes for effective therapeutics.

Authors:  Zhaoyang Ye; Ram I Mahato
Journal:  Mol Pharm       Date:  2011-10-03       Impact factor: 4.939

4.  Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.

Authors:  Brigitte Anliker; Tobias Abel; Sabrina Kneissl; Juraj Hlavaty; Antonio Caputi; Julia Brynza; Irene C Schneider; Robert C Münch; Helga Petznek; Roland E Kontermann; Ulrike Koehl; Ian C D Johnston; Kari Keinänen; Ulrike C Müller; Christine Hohenadl; Hannah Monyer; Klaus Cichutek; Christian J Buchholz
Journal:  Nat Methods       Date:  2010-10-10       Impact factor: 28.547

5.  Insights into neurogenesis and aging: potential therapy for degenerative disease?

Authors:  Robert A Marr; Rosanne M Thomas; Daniel A Peterson
Journal:  Future Neurol       Date:  2010-07-01

6.  Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell.

Authors:  Luca Biasco; Alessandro Ambrosi; Danilo Pellin; Cynthia Bartholomae; Immacolata Brigida; Maria Grazia Roncarolo; Clelia Di Serio; Christof von Kalle; Manfred Schmidt; Alessandro Aiuti
Journal:  EMBO Mol Med       Date:  2011-01-17       Impact factor: 12.137

7.  High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages.

Authors:  Chengxiang Wu; Yuanan Lu
Journal:  J Gen Virol       Date:  2010-04-21       Impact factor: 3.891

8.  Abrogated cryptic activation of lentiviral transfer vectors.

Authors:  Ralf M Luche; Joerg Enssle; Hans-Peter Kiem
Journal:  Sci Rep       Date:  2012-06-01       Impact factor: 4.379

9.  A single epidermal stem cell strategy for safe ex vivo gene therapy.

Authors:  Stéphanie Droz-Georget Lathion; Ariane Rochat; Graham Knott; Alessandra Recchia; Danielle Martinet; Sara Benmohammed; Nicolas Grasset; Andrea Zaffalon; Nathalie Besuchet Schmutz; Emmanuelle Savioz-Dayer; Jacques Samuel Beckmann; Jacques Rougemont; Fulvio Mavilio; Yann Barrandon
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

10.  The Business of RNAi Therapeutics in 2012.

Authors:  Dirk Haussecker
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-07       Impact factor: 10.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.